Cargando…

Amelioration of muscle and nerve pathology of Lama2-related dystrophy by AAV9-laminin-αLN linker protein

LAMA2 deficiency, resulting from a defective or absent laminin α2 subunit, is a common cause of congenital muscular dystrophy. It is characterized by muscle weakness from myofiber degeneration and neuropathy from Schwann cell amyelination. Previously it was shown that transgenic muscle-specific expr...

Descripción completa

Detalles Bibliográficos
Autores principales:	McKee, Karen K., Yurchenco, Peter D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Clinical Investigation 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310540/ https://www.ncbi.nlm.nih.gov/pubmed/35639486 http://dx.doi.org/10.1172/jci.insight.158397

Ejemplares similares

Amelioration of Muscle and Nerve Pathology in LAMA2 Muscular Dystrophy by AAV9-Mini-Agrin
por: Qiao, Chunping, et al.
Publicado: (2018)

Linker Protein Repair of LAMA2 Dystrophic Neuromuscular Basement Membranes
por: Yurchenco, Peter D., et al.
Publicado: (2019)

Cryo-EM reveals the molecular basis of laminin polymerization and LN-lamininopathies
por: Kulczyk, Arkadiusz W., et al.
Publicado: (2023)

Nerve pathology is prevented by linker proteins in mouse models for LAMA2-related muscular dystrophy
por: Reinhard, Judith R, et al.
Publicado: (2023)

Linker molecules between laminins and dystroglycan ameliorate laminin-α2–deficient muscular dystrophy at all disease stages
por: Meinen, Sarina, et al.
Publicado: (2007)

Laminin and Integrin in LAMA2-Related Congenital Muscular Dystrophy: From Disease to Therapeutics
por: Barraza-Flores, Pamela, et al.
Publicado: (2020)

Chimeric protein identification of dystrophic, Pierson and other laminin polymerization residues
por: McKee, Karen K., et al.
Publicado: (2018)

Deletion of exon 4 in LAMA2 is the most frequent mutation in Chinese patients with laminin α2-related muscular dystrophy
por: Ge, Lin, et al.
Publicado: (2018)

Transgenic Expression of Human LAMA5 Suppresses Murine Lama5 mRNA and Laminin α5 Protein Deposition
por: Steenhard, Brooke M., et al.
Publicado: (2011)

Exogenous laminin exhibits a unique vascular pattern in the brain via binding to dystroglycan and integrins
por: Ruan, Jingsong, et al.
Publicado: (2022)

Laminins in basement membrane assembly
por: Hohenester, Erhard, et al.
Publicado: (2013)

A Family of Laminin α2 Chain-Deficient Mouse Mutants: Advancing the Research on LAMA2-CMD
por: Gawlik, Kinga I., et al.
Publicado: (2020)

Laminin–sulfatide binding initiates basement membrane assembly and enables receptor signaling in Schwann cells and fibroblasts
por: Li, Shaohua, et al.
Publicado: (2005)

Human laminin-111 and laminin-211 protein therapy prevents muscle disease progression in an immunodeficient mouse model of LAMA2-CMD
por: Barraza-Flores, Pamela, et al.
Publicado: (2020)

Laminin Polymerization Induces a Receptor–Cytoskeleton Network
por: Colognato, Holly, et al.
Publicado: (1999)

Magnetic Resonance Imaging Is Sensitive to Pathological Amelioration in a Model for Laminin-Deficient Congenital Muscular Dystrophy (MDC1A)
por: Vohra, Ravneet, et al.
Publicado: (2015)

Outcome Measures for COL6 and LAMA2-Related Dystrophies
por: Schwaede, Abigail N., et al.
Publicado: (2020)

CRISPRa-induced upregulation of human LAMA1 compensates for LAMA2-deficiency in Merosin-deficient congenital muscular dystrophy
por: Arockiaraj, Annie I., et al.
Publicado: (2023)

Tumour-Derived Laminin α5 (LAMA5) Promotes Colorectal Liver Metastasis Growth, Branching Angiogenesis and Notch Pathway Inhibition
por: Gordon-Weeks, Alex, et al.
Publicado: (2019)

Dysregulation of matricellular proteins is an early signature of pathology in laminin-deficient muscular dystrophy
por: Mehuron, Thomas, et al.
Publicado: (2014)

Whole-Genome Sequencing of Invasion-Resistant Cells Identifies Laminin α2 as a Host Factor for Bacterial Invasion
por: van Wijk, Xander M., et al.
Publicado: (2017)

Current understanding and treatment of cardiac and skeletal muscle pathology in laminin-α2 chain-deficient congenital muscular dystrophy
por: Nguyen, Quynh, et al.
Publicado: (2019)

LAMA2 Nonsense Variant in an Italian Greyhound with Congenital Muscular Dystrophy
por: Christen, Matthias, et al.
Publicado: (2021)

Correction: dysregulation of matricellular proteins is an early signature of pathology in laminin-deficient muscular dystrophy
por: Mehuron, Thomas, et al.
Publicado: (2014)

A laminin 511 matrix is regulated by TAZ and functions as the ligand for the α6Bβ1 integrin to sustain breast cancer stem cells
por: Chang, Cheng, et al.
Publicado: (2015)

Cobblestone Malformation in LAMA2 Congenital Muscular Dystrophy (MDC1A)
por: Jayakody, Himali, et al.
Publicado: (2020)

Congenital muscular dystrophy in a dog with a LAMA2 gene deletion
por: Shelton, G. Diane, et al.
Publicado: (2021)

An atypical expression of core α-Dystroglycan and Laminin-α2 in skin fibroblasts of patients with congenital muscular dystrophies
por: Sabry, Sahar, et al.
Publicado: (2023)

LAMA2 Congenital Muscle Dystrophy: A Novel Pathogenic Mutation in Bulgarian Patient
por: Dimova, Ivanka, et al.
Publicado: (2018)

Novel LAMA2 Gene Mutations Associated with Merosin-Deficient Congenital Muscular Dystrophy
por: Hashemi-Gorji, Feyzollah, et al.
Publicado: (2018)

LAMA2‐related muscular dystrophy: Natural history of a large pediatric cohort
por: Zambon, Alberto A., et al.
Publicado: (2020)

Zebrafish Models of LAMA2-Related Congenital Muscular Dystrophy (MDC1A)
por: Fabian, Lacramioara, et al.
Publicado: (2020)

LAMA2-Related Dystrophies: Clinical Phenotypes, Disease Biomarkers, and Clinical Trial Readiness
por: Sarkozy, Anna, et al.
Publicado: (2020)

Fibrogenesis in LAMA2-Related Muscular Dystrophy Is a Central Tenet of Disease Etiology
por: Accorsi, Anthony, et al.
Publicado: (2020)

Laminin-induced Clustering of Dystroglycan on Embryonic Muscle Cells: Comparison with Agrin-induced Clustering
por: Cohen, Monroe W., et al.
Publicado: (1997)

A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin
Publicado: (1993)

Dalai Lama
Publicado: (2020)

Dalaï-Lama
Publicado: (2020)

Lamas in loops
por: Lai, Eric C.
Publicado: (2003)

Long-term follow-up of laminin α2 (merosin)-deficient muscular dystrophy in a cat
por: Awamura, Yuichi, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_40j95nud7337oa8u7j3o21r8vc